Published in Gene Therapy Weekly, March 2nd, 2006
"IFN-inducible proteins are known to mediate IFN-directed antitumor effects. The human IFN-inducible protein AIM2 gene encodes a 39-kDa protein, which contains a 200-amino-acid repeat as a signature of HIN-200 family (hematopoietic IFN-inducible nuclear proteins)," wrote I.F. Chen and colleagues, M.D. Anderson Cancer Center.
"Although AIM2 is known to inhibit fibroblast cell growth in vitro, its antitumor activity has not been shown. Here, we showed that AIM2 expression...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.